Clinical Trial Update: Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP) [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing Icaritin Soft Capsule versus Huachansu Tablet as first-line therapy for unresectable hepatocellular carcinoma with poor progn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Huachansu Tablet (huachansu)
• Icaritin Soft Capsule (icaritin)

Snippet

Sponsor: Beijing Shenogen Biomedical Co., Ltd | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: RECRUITING